A closer look at the technologies used by Essential Pharma
See more technologies
Essential Pharma
Manufacturing · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
8A Crabtree Road, Egham, Surrey, TW20 8R...Phone Number
+44 1784477167Website
www.essentialpharmagroup.comRevenue
$35.4 MillionIndustry
About Essential Pharma
Essential Pharma is a specialist pharmaceutical company dedicated to ensuring access to essential medicines, particularly for small, underserved, or rare disease populations. The company focuses on developing and delivering high-quality therapies, including those at risk of discontinuation, across various therapeutic areas such as rare diseases, CNS, ophthalmology, and gastroenterology. With a growing portfolio of products available in approximately 70 countries, Essential Pharma aims to address significant unmet medical needs. Their commitment to corporate responsibility and innovation drives their mission to transform lives through reliable healthcare solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Essential Pharma
Compare insights from companies similar to Essential Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Essential Pharma
$35.4M
51-200
Private
$936M
2000
N/A
Essential Pharma Tech Stack
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Essential Pharma
Sign Up For FreeTo access detailed company insights
Essential Pharma is a specialist pharmaceutical company dedicated to ensuring access to essential medicines, particularly for small, underserved, or rare disease populations. The company focuses on developing and delivering high-quality therapies, including those at risk of discontinuation, across various therapeutic areas such as rare diseases, CN... Read More
